TerminatedNot Applicable

RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures

Stopped: Slower than expected enrollment.

United States4 participantsStarted 2018-08-01

Plain-language summary

There is currently no consensus amongst orthopedic specialists on the best way to treat 3- and 4-part proximal humerus fractures. No surgery and surgery with a type of shoulder replacement called a reverse total shoulder arthroplasty are two options that many orthopedists use. This study is being performed to evaluate the differences in short- and long-term pain and functional outcomes between patients who are treated with these two different options.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * Displaced 3- and 4-part proximal humerus fractures. * Age greater than or equal to 65 years old. Exclusion Criteria * Less than 65 years old. * Medical comorbidities precluding surgical treatment or anesthesia * Dementia or inability to provide adequate follow up. * Pathologic fractures * Open fractures * Associated injuries: fracture dislocations, multiple or complex injuries of the ipsilateral limb, complete brachial plexopathy, vascular injury and polytrauma.

What they're measuring

Function as described by ASES score at 1 year follow-up.

Timeframe: 2 year follow-up

Trial details

NCT IDNCT03599336

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-10-29

View on ClinicalTrials.gov More Humerus Fracture trials